 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orchid Pharma Consolidated June 2023 Net Sales at Rs 182.92 crore, up 39.65% Y-o-Y

Orchid Pharma Standalone June 2023 Net Sales at Rs 182.92 crore, up 39.65% Y-o-Y

The company raised a total Rs 400 crore from these investors.

Orchid Pharma hits 52-week high on raising Rs 400 crore through QIP

Orchid Pharma Consolidated March 2023 Net Sales at Rs 209.90 crore, up 17.83% Y-o-Y

Orchid Pharma Standalone March 2023 Net Sales at Rs 209.90 crore, up 16.46% Y-o-Y

Orchid Pharma Consolidated December 2022 Net Sales at Rs 159.76 crore, down 1% Y-o-Y

Orchid Pharma Standalone December 2022 Net Sales at Rs 159.76 crore, up 0.29% Y-o-Y

Orchid Pharma Consolidated June 2022 Net Sales at Rs 130.99 crore, up 41.9% Y-o-Y

Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectibles, veterinary products, and non-antibiotics. The company was founded by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Chennai, India.

Watchers	2
52-Wk Low	316.25
52-Wk High	634.80

Market Cap	26.04B
Volume (M)	40,292.00
52-Wk High	634.80
52-Wk Low	316.25

ORCHPHARMA.NSE Orchid Pharma Ltd

About

Feed

News

Fundamentals